Recent Analysts’ Ratings Changes for Omada Health (OMDA)

Omada Health (NASDAQ: OMDA) recently received a number of ratings updates from brokerages and research firms:

• 8/14/2026 – Omada Health had its “outperform” rating reaffirmed by Citigroup Inc..
• 8/14/2026 – Omada Health had its price target raised by JPMorgan Chase & Co. from $26.00 to $30.00. They now have an “overweight” rating on the stock.
• 8/14/2026 – Omada Health had its price target raised by Citizens Jmp from $27.00 to $32.00. They now have a “market outperform” rating on the stock.
• 8/12/2026 – Omada Health had its price target raised by Robert W. Baird from $15.00 to $25.00. They now have a “neutral” rating on the stock.
• 8/11/2026 – Omada Health was upgraded by Weiss Ratings from “sell (e+)” to “sell (d+)”.
• 8/10/2026 – Omada Health had its price target raised by BTIG Research from $30.00 to $35.00. They now have a “buy” rating on the stock.
• 8/8/2026 – Omada Health was upgraded by Wall Street Zen from “hold” to “buy”.
• 8/7/2026 – Omada Health had its “outperform” rating reaffirmed by BMO Capital Markets. They now have a $24.00 price target on the stock.
• 8/3/2026 – Omada Health had its price target raised by Barclays PLC from $20.00 to $25.00. They now have an “overweight” rating on the stock.
• 7/21/2026 – Omada Health had its price target raised by Canaccord Genuity Group Inc. from $24.00 to $28.00. They now have a “buy” rating on the stock.
• 7/20/2026 – Omada Health had its “outperform” rating reaffirmed by Citigroup Inc..
• 7/20/2026 – Omada Health had its price target raised by Citizens Jmp from $21.00 to $27.00. They now have a “market outperform” rating on the stock.
• 7/18/2026 – Omada Health was downgraded by Wall Street Zen from “buy” to “hold”.
• 7/17/2026 – Omada Health is now covered by BTIG Research. They set a “buy” rating and a $30.00 price target on the stock.
• 7/17/2026 – Omada Health is now covered by BTIG Research. They set a “buy” rating and a $30.00 price target on the stock.
• 7/13/2026 – Omada Health was downgraded by Weiss Ratings from “sell (d-)” to “sell (e+)”.
• 6/27/2026 – Omada Health was upgraded by Wall Street Zen from “hold” to “buy”.
• 6/26/2026 – Omada Health was upgraded by Weiss Ratings from “sell (e+)” to “sell (d-)”.
• 6/22/2026 – Omada Health had its “overweight” rating reaffirmed by Morgan Stanley. They now have a $30.00 price target on the stock.

Insiders Place Their Bets

In related news, CFO Steven L. Cook sold 33,000 shares of the firm’s stock in a transaction on Friday, June 26th. The stock was sold at an average price of $19.89, for a total value of $656,370.00. Following the transaction, the chief financial officer owned 133,359 shares in the company, valued at approximately $2,652,510.51. This trade represents a 19.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Sean P. Duffy sold 25,886 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $22.68, for a total transaction of $587,094.48. Following the completion of the transaction, the chief executive officer directly owned 411,861 shares in the company, valued at approximately $9,341,007.48. This represents a 5.91% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 254,726 shares of company stock worth $5,370,496. Corporate insiders own 6.38% of the company’s stock.

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.